Marloes van der Geer

Marloes van der Geer

24 Jun, 2025

Marloes provides regulatory affairs consultancy and services to both big- and small-sized pharmaceutical companies, covering a wide variety of products.

Marloes holds a master in Life Sciences (Drug Innovation) from the University of Utrecht, the Netherlands.

For nine years she held several positions at Hoffmann-la Roche in Switzerland, including the role of regulatory intelligence manager and regulatory policy lead for the EMEA region. Awarded DIA Leader of Tomorrow in 2016. Helped author the biosimilar guidelines across the globe.

Other Related Articles

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review

Blog Medical Devices

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review

22 Jul, 2026

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports

Blog Medical Devices

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports

21 Jul, 2026

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs

Blog Pharmaceutical

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs

15 Jul, 2026

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation

Blog Medical Devices

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation

08 Jul, 2026

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance

Blog Pharmaceutical

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance

02 Jul, 2026

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive

Blog Pharmaceutical

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive

26 Jun, 2026

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective

Blog Medical Devices

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective

17 Jun, 2026

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics

Blog Pharmaceutical

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics

05 Jun, 2026

View All